Project Grant K99HL175031
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$171K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $766,920 to the Augusta University Research Institute, Inc. to conduct research on the mechanisms linking skeletal muscle metabolism and vascular health in obesity. The key objectives are to determine how obesity-induced increases in the enzyme CYP1B1, lipid accumulation in skeletal muscle (myosteatosis), and upregulation of the...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research Program (CFDA 93.837) provides $705,279 to Boston University to investigate the effects of environmental pollutants on the cardiovascular system. The research aims to characterize how lipophilic pollutants and "forever chemicals" impact vascular function, angiogenesis, and inflammation, with a focus on understanding the pathogenic mechanisms involving...
This $1,057,905 Project Grant awarded by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will support a comprehensive program of research to promote weight-related health in the next generation of adolescents and young adults. The research will collect data on a national sample of 2,000 Gen Z adolescents and young adults, as well as 1,000 parent-child dyads spanning Gen Z and Millennial generations, to provide the most comprehensive dataset to date on...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $179,280 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, CA. The grant will fund a 5-year research project focused on addressing disparities in polygenic risk scores for coronary heart disease (CHD) across diverse populations. The project aims to (1) explore population-specific differences in genetic...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to investigate the role of hepatic steatosis (non-alcoholic fatty liver disease) in the development of cardiovascular disease, independent of obesity and metabolic dysfunction. The $604,818 award will fund research to determine if increasing plasma levels of β-hydroxybutyrate (a ketone body) or PPAR-α-regulated hepatokines (nerve growth...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $115,949 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the impact of obesity on the visceral adipose tissue (VAT) immune-stromal niche. The primary objective is to delineate the spatial and temporal relationships between immune cells and fibroblasts in the expanding VAT during obesity,...
This federal Project Grant award of $181,980.00 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to investigate the relationship between epicardial adipose tissue (EAT) and cardiometabolic health in adolescents with youth-onset type 2 diabetes (Y-T2D). The research will use novel cardiac MRI methods to assess cardiac structure and function, including EAT volume, and explore the impact of metabolic and bariatric...
This $817,208 Project Grant was awarded on January 3, 2025 by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant supports research at the Broad Institute of MIT and Harvard to investigate the genetic basis and underlying mechanisms of heart failure (HF). The project will leverage high-throughput assays, including cell painting and Perturb-seq, to link genes associated with HF risk through genome-wide association...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $743,302 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The 4-year grant will fund research to investigate how gut microbe-derived lipids, specifically n-acyl amides, can signal through the host G protein-coupled receptor GPR119 to regulate inflammatory and metabolic pathways related to cardiometabolic diseases like...
This federal Project Grant award of $1,399,182 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to generate new insights on the early identification and prevention of adult coronary heart disease (CHD). The project, titled "Early Developmental Risk for Adult Cardiovascular Disease: High Risk Subgroups, Biomarkers, and Mechanisms," will comprehensively assess approximately 800 small for gestational age (SGA)...